June 07, 2022 at 4:42 pm

Soligenix Moves Forward with Treatments for Cutaneous T-Cell Lymphoma and Psoriasis

Strategy supports global need and has potential use in growing home healthcare market Rising to the challenge in 2022, late-stage biopharma company Soligenix (Nasdaq:SNGX) continues to move forward with developing and commercializing products to treat rare diseases where there is an unmet medical need. At the forefront of the company’s pipeline is HyBryte™, a treatment… [Read More]
June 03, 2022 at 3:26 pm

Lexaria Grants Exclusive License to Premier Wellness Science for Japanese Market

Expanding its footprint in the Japanese health and wellness market, Lexaria Bioscience (NASDAQ:LEXX), has signed an exclusive commercial licensing agreement with Premier Wellness Science Co. Ltd. Lexaria, a global innovator in drug delivery platforms, will exclusively license its DehydraTECH technology in Japan for use with CBD and hemp ingredients, with minimum payments to surpass $4.5… [Read More]
June 02, 2022 at 6:46 pm

Workhorse Group (WKHS) Shoots Up on News From USPS

Workhorse Group (WKHS) shot up 15% today on news from USPS that they will likely be ordering more electric trucks for the postal agency’s next-generation fleet. Workhorse designs and builds battery-electric trucks and can potentially stand to benefit from USPS’s decision. The decision by USPS follows backlash and sharp criticism of their ordering of a… [Read More]
May 26, 2022 at 8:23 pm

Apyx Medical Corp (APYX) Skyrockets 52% on FDA Granting Clearance

Apyx Medical Corp (APYX) shot up around 52% on news that the FDA granted clearance for the use of its Renuvion cosmetic technology in certain dermal resurfacing procedures. Renuvion is indicated for the treatment of moderate to severe wrinkles and rhytides in patients with Fitzpatrick skin types I, II or III, according to the Company…. [Read More]
May 24, 2022 at 5:34 pm

Why Soligenix Shares Jumped 10% Yesterday

After the news that it received a U.S. patent allowance for its vaccine platform, Soligenix (Nasdaq:SNGX) shares recorded a double-digit jump of 10% yesterday. The late-stage biopharma focused on developing and commercializing products to treat rare diseases reported that the U.S. Patent and Trademark Office issued a Notice of Allowance for its patent application, “Compositions and… [Read More]
May 23, 2022 at 4:09 pm

Quoin Pharmaceuticals (NASDAQ:QNRX) Signs Second Exclusive Research Agreement with Australian University

Advancing scientific research into developing treatments for rare and orphan diseases, Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) signed a second exclusive research agreement with the Queensland University of Technology (QUT) in Australia. The new agreement centers on a potential treatment for scleroderma, a rare autoimmune disease that affects connective tissue of the skin, blood vessels, internal… [Read More]
May 17, 2022 at 8:23 pm

IonQ (IONQ) Jumps on Announcement of IonQ Forte – Its Latest Generation of Quantum Systems

IonQ (IONQ) received a surge of around 17.5% upon their announcement of its latest generation of quantum systems. The new system, IonQ Forte, features novel, cutting-edge optics technology that enables increased accuracy and further enhances IonQ’s system performance. Forte is expected to be initially available for select developers, partners and researchers in 2022 and for… [Read More]
May 12, 2022 at 8:34 pm

Inovio Pharmaceuticals (INO) Down Almost 33% For the Week

Inovio Pharmaceuticals (INO) tumbled almost 33% over the past week. The investor sell-off is largely in part due to the Company’s shift in focus from a Covid-19 vaccine to a Covid-19 booster. This also comes on the heels of their Q1’22 financial results and the appointment of a new CEO – Jacqueline Shea, Ph.D. “We… [Read More]
May 11, 2022 at 9:58 pm

GrowGeneration (GRWG) Tumbles on Earnings Miss

GrowGeneration (GRWG) missed on earnings, causing GRWG to fall almost 23% for the day. The Company reported a revenue of $81.8M in Q1’22 which declined 9% YoY, highlighting weak demand in the cannabis industry. In response, GRWG trimmed their outlook for 2022 overall. GRWG is housed in the PRISM Cannabis Index, which fell 8.2% for… [Read More]
May 07, 2022 at 5:52 pm

T2 Biosystems (TTOO) Falls 21% From Q1 Earnings

T2 Biosystems (TTOO) fell sharply around 21% upon the release of their Q1 earnings. The Q1 report indicated a larger net loss for the quarter than last year’s, which disappointed investors. The net loss for the first quarter of 2022 was $16.5M compared to a net loss of $10.7M in 2021. On the positive side,… [Read More]